Home > > > > Report Detail

North America Hyperphosphatemia Drug Market Forecast 2019-2027

Publisher Name :
Date: 19-Nov-2018
No. of pages: 80

Key Findings

The North America hyperphosphatemia drug market is expected to grow at a CAGR of 15.19% over the forecast period. The region is expected to hold the largest share in the market with an anticipated increase in the revenue from $xx million in 2018 to $xx million by 2027. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. Increasing prevalence of these chronic diseases along with unattended medical needs are driving the hyperphosphatemia drug market in this region.

Market Insights

The changing dietary patterns along with the increasing cases of osteoporosis diseases in countries like the United States and Canada are providing the hyperphosphatemia drug market with plenty of growth opportunities. The market is mainly categorized by the different types of drug binders such as iron-based phosphate binders, magnesium-based phosphate binders, aluminium-based phosphate binders, calcium-based phosphate binders and others. The aluminium-based phosphate binders generated revenue of $203 million in 2016 and are widely used with magnesium-based phosphate binders for treating patients on dialysis. However, it is the calcium-based phosphate binders that held the largest market share of xx% in 2018 and are expected to continue their dominance throughout the forecasted period. Despite such phenomenal growth, the market is facing some tough challenges due to the various limitations imposed by the Food and Drug Administration (FDA) and the rising side effects observed due to the use of some of the hyperphosphatemia drugs.

Competitive Insights

Some of the eminent companies in the hyperphosphatemia drug market include Royal Dsm, Amag, Sun Pharma, and Keryx. Other top players in the market are Zeria Pharmaceutical, Johnson and Johnson, Bruno Pharmaceutical Spa, Cipla, Ultragenyx, Fresenius Medical Care, Roche Diagnostics Corporation, R.H. Moore Drug Co., Sanofi, Fermenta Biotech Ltd, Vifor Pharma, Shire and Pfizer Inc.

North America Hyperphosphatemia Drug Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Iron-Based Hyperphosphatemia Drugs Is A Game Changer
4. Market Determinants
4.1. Market Scope & Definition
4.2. Drivers
4.2.1. Growing Prevalence of Chronic Diseases
4.2.2. Unmet Medical Needs
4.2.3. Skewed Population Mix Towards Elderly People
4.2.4. Rise In Public Awareness
4.3. Restraints
4.3.1. Limitations Levied By The Food And Drug Administration (Fda)
4.3.2. Growing Side Effects of The Hyperphosphatemia Drugs
4.4. Challenges
4.4.1. Non-Adherence To Treatment Regimens
4.4.2. Side Effects of Drugs
4.4.3. Limited Availability of Drugs
4.4.4. Use of Advanced Dialysis Techniques
4.5. Market By Dosage
4.5.1. Solid
4.5.1.1. Tablet
4.5.1.2. Powder
4.5.2. Liquid
4.5.2.1. Solution
5. Market By Formulation
5.1.1. Calcium-Based Phosphate Binders
5.1.2. Aluminum-Based Phosphate Binders
5.1.3. Magnesium-Based Phosphate Binders
5.1.4. Iron-Based Phosphate Binders
5.1.5. Other Phosphate Binders
6. Key Analytics
6.1. Porter's Five Force Model
6.1.1. Threat of New Entrants
6.1.2. Bargaining Power of Buyers
6.1.3. Bargaining Power of Suppliers
6.1.4. Threat of Substitute Product
6.1.5. Intensity of Competitive Rivalry
6.2. Opportunity Matrix
6.3. Key Buying Criteria
6.3.1. Application
6.3.2. Pricing
6.3.3. Effectiveness
6.3.4. Availability
6.4. Strategic Recommendation & Strategic Conclusions
6.5. Market Trends
6.5.1. Patient Assistance Programs
6.5.2. Strategic Alliances
6.5.3. Increase In R&D
6.6. Phosphate Binders Usages Guidelines
7. Geographic Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Amag Pharmaceuticals
8.2.1.1. Overview
8.2.1.2. Product Portfolio
8.2.1.3. Scot Analysis
8.2.1.4. Strategic Initiatives
8.2.2. Biotech Pharmacal
8.2.2.1. Overview
8.2.2.2. Products Portfolio
8.2.2.3. Scot Analysis
8.2.2.4. Strategic Initiatives
8.2.3. Bruno Farmaceutici Spa
8.2.3.1. Overview
8.2.3.2. Product Portfolio
8.2.3.3. Scot Analysis
8.2.3.4. Strategic Initiatives
8.2.4. Cipla
8.2.4.1. Overview
8.2.4.2. Product Portfolio
8.2.4.3. Scot Analysis
8.2.4.4. Strategic Initiatives
8.2.5. Fermenta Biotech Ltd
8.2.5.1. Overview
8.2.5.2. Product Portfolio
8.2.5.3. Scot Analysis
8.2.5.4. Strategic Initiatives
8.2.6. Fresenius Medical Care
8.2.6.1. Overview
8.2.6.2. Product Portfolio
8.2.6.3. Scot Analysis
8.2.6.4. Strategic Initiatives
8.2.7. Johnson And Johnson
8.2.7.1. Company Overview
8.2.7.2. Product Portfolio
8.2.7.3. Scot Analysis
8.2.7.4. Strategic Initiatives
8.2.8. Keryx Biopharmaceuticals Inc
8.2.8.1. Overview
8.2.8.2. Scot Analysis
8.2.8.3. Strategic Initiatives
8.2.9. Pfizer Inc.
8.2.9.1. Overview
8.2.9.2. Product Portfolio
8.2.9.3. Scot Analysis
8.2.9.4. Strategic Initiatives
8.2.10. Roche Diagnostics Corporation
8.2.10.1. Overview
8.2.10.2. Product Portfolio
8.2.10.3. Scot Analysis
8.2.10.4. Strategic Initiatives
8.2.11. Royal Dsm N.V.
8.2.11.1. Overview
8.2.11.2. Product Portfolio
8.2.11.3. Scot Analysis
8.2.11.4. Strategic Initiatives
8.2.12. Sanofi
8.2.12.1. Overview
8.2.12.2. Product Portfolio
8.2.12.3. Scot Analysis
8.2.12.4. Strategic Initiatives
8.2.13. Shire
8.2.13.1. Overview
8.2.13.2. Product Portfolio
8.2.13.3. Scot Analysis
8.2.13.4. Strategic Initiatives
8.2.14. Sun Pharmaceutical Industries Ltd
8.2.14.1. Overview
8.2.14.2. Products Portfolio
8.2.14.3. Scot Analysis
8.2.14.4. Strategic Initiatives
8.2.15. Ultragenyx Pharmaceutical Inc.
8.2.15.1. Overview
8.2.15.2. Product Portfolio
8.2.15.3. Scot Analysis
8.2.15.4. Strategic Initiatives
8.2.16. Zeria Pharmaceutical
8.2.16.1. Overview
8.2.16.2. Product Portfolio
8.2.16.3. Scot Analysis
8.2.16.4. Strategic Initiatives

List of Tables

Table 1 North America Hyperphosphatemia Drug Market 2019-2027($ Million)
Table 2 Iron-Based Hyperphosphatemia Drug Approval Status 2014-2017
Table 3 Worldwide Population Aged 80 And Above 1950-2050 (Millions)
Table 4 Phosphorous Levels In Select Foods
Table 5 North America Hyperphosphatemia Drugs Market By Formulation 2019-2027($ Million)
Table 6 North America Calcium-Based Phosphate Binders 2019-2027($ Million)
Table 7 North America Aluminum-Based Phosphate Binders 2019-2027($ Million)
Table 8 North America Magnesium-Based Phosphate Binders 2019-2027($ Million)
Table 9 North America Iron-Based Phosphate Binders 2019-2027($ Million)
Table 10 North America Other Phosphate Binders 2019-2027($ Million)
Table 11 Pipeline Portfolio of Hyperphosphatemia Drugs
Table 12 North America Hyperphosphatemia Drugs Market 2019-2027 ($ Million)
Table 13 North America Hyperphosphatemia Drugs Market By Country 2019-2027($ Million)

List of Figures

Figure 1 Rate of Adherence To Phosphate Binders
Figure 2 Diagnosis And Clinical Indicators of Chronic Kidney Disease
Figure 3 North America Hyperphosphatemia Drugs Market By Calcium-Based Phosphate Binders 2019-2027($ Million)
Figure 4 North America Hyperphosphatemia Drugs Market By Aluminum-Based Phosphate Binders 2019-2027($ Million)
Figure 5 North America Hyperphosphatemia Drugs Market By Magnesium-Based Phosphate Binders 2019-2027($ Million)
Figure 6 North America Hyperphosphatemia Drugs Market By Iron-Based Phosphate Binders 2019-2027($ Million)
Figure 7 North America Hyperphosphatemia Drugs Market By Other Phosphate Binders 2019-2027($ Million)
Figure 8 Porters 5 Force Model of Hyperphosphatemia Market
Figure 9 North America Hyperphosphatemia Drugs Market Share, 2019 & 2027 (%)
Figure 10 North America Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 11 The United States Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 12 Canada Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 13 Market Share Analysis of Key Players 2017 (%)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs